Healthcare -
Biotechnology - NASDAQ - CA
$ 0.791
-5.66 %
$ 61 M
Market Cap
-3.16
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
43.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Oncolytics Biotech Inc.
ONCY has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ONCY
EBIT FORECAST
EBIT Forecast Chart ONCY
NET INCOME FORECAST
Net Income Chart ONCY